Header Logo

Connection

Joshua Marcus to Mechanistic Target of Rapamycin Complex 1

Back to Details
This is a "connection" page, showing publications Joshua Marcus has written about Mechanistic Target of Rapamycin Complex 1.
Joshua Marcus
Connection Strength
0.041
Mechanistic Target of Rapamycin Complex 1
  1. Preclinical and Dose-Finding Phase I Trial Results of Combined Treatment with a TORC1/2 Inhibitor (TAK-228) and Aurora A Kinase Inhibitor (Alisertib) in Solid Tumors. Clin Cancer Res. 2020 09 01; 26(17):4633-4642.
    View in: PubMed
    Score: 0.041
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.